TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
LNTH

Lantheus Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

100.00$ +0.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow LNTH
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
3.8% 7.4% 16.4% 16.5% 17.8% 23.1% 4.8% 12.7% 30.1% 23.5% 35.5% 25.3%
6.1% 6.7% 6.1% 5.8% 4.1% 3.9% 7.3% 9.9% 5.1% 4.6% 4.2% 4.5%
0.3% 0.7% 0.8% 1.8% 2.5% 3.6% 4.1% 3.7% 3.1% 3.9% 5.0% 5.6%
0.0% 7.4% -0.4% 3.5% 3.9% 5.2% 8.3% 22.9% 7.5%
-3.9% -2.8% 0.7% -2.5% -4.1% 2.6% -6.6% -3.6% -8.0% -13.2% 0.1% -2.9%
2.7% 4.5% 2.5% 5.3% 5.9% 6.4% 3.7% 2.9% 2.0% 3.6% 3.4% 2.3%
-2.5% -4.5% 1.1% -4.9% -5.6% -6.4% -1.4% 0.9% -29.6% 0.5% -14.7% -40.7%
0.0% 0.0% 0.0% 0.7% 0.6% 0.5%
0.0% 0.0% -0.2% -0.9% -1.0% -0.7% -0.6% -0.5% -8.0% -1.1% -6.5% -19.5%
0.0% -22.3% -26.1% -4.2% -0.8% -22.5% -4.9% -10.2% 40.9% -0.1% 0.0% -0.1%
-0.8% 0.3% -10.0% -4.1% -1.4% -22.7% -6.4% -9.3% 33.3% -1.0% -7.7% -20.5%
0.4% 3.0% 7.5% 7.6% 10.8% -5.9% -3.0% 4.2% 33.9% 23.0% 13.0% -35.9%
1.1% 2.9% 14.0% 11.2% 12.0% 16.8% 1.2% 9.8% 28.2% 20.0% 32.1% 23.0%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?